Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
12/16/2010 | US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
12/16/2010 | US20100316702 Compositions and methods for regulating erythropoeitin expression and ameliorating anemia and stimulating erythropoiesis |
12/16/2010 | US20100316694 Novel filter composites for drug detoxification |
12/16/2010 | US20100316625 Stabilized factor ix formulations containing trehalose |
12/16/2010 | US20100316618 Lactic acid bacterium having effect of lowering blood uric acid level |
12/16/2010 | US20100316601 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
12/16/2010 | US20100316578 Oral compositions for absorption of phosphorous compounds |
12/16/2010 | CA2764638A1 Treatment of coagulopathy with hyperfibrinolysis |
12/16/2010 | CA2764189A1 Use of lcat for treating anemia and red blood cell dysfunction |
12/16/2010 | CA2764172A1 A thrombin receptor antagonist and clopidogrel fixed dose tablet |
12/16/2010 | CA2764105A1 Growth hormone polypeptides and methods of making and using same |
12/16/2010 | CA2762916A1 Salts of bicyclo-substituted pyrazolon azo derivatives, preparation method and use thereof |
12/15/2010 | EP2261251A2 Methods for the synthesis of a modified hemoglobin solution |
12/15/2010 | EP2261250A1 Albumin fusion proteins |
12/15/2010 | EP2261235A2 Inhibitors of caspases |
12/15/2010 | EP2261234A2 Inhibitors of caspases |
12/15/2010 | EP2261233A2 Inhibitors of caspases |
12/15/2010 | EP2261232A2 Inhibitors of caspases |
12/15/2010 | EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor |
12/15/2010 | EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents |
12/15/2010 | EP2260048A1 Porous crystalline hybrid solid for adsorbing and releasing gas of biological interest |
12/15/2010 | EP2259786A2 Method for inhibiting the build-up of arterial plaque by administering fullerenes |
12/15/2010 | EP2000465B1 Triazolone derivative |
12/15/2010 | EP1537146B1 Antibodies binding to anionic phospholipids and aminophospholipids and their use in treating viral infections |
12/15/2010 | EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof |
12/15/2010 | EP1276463B1 Hemostatic agent, method and carrier for applying a blood clotting agent |
12/15/2010 | CN1939357B Preparation of Ginkgo Damo injection |
12/15/2010 | CN1927346B Mailuoning injection and preparation thereof |
12/15/2010 | CN1919848B bilobalide K and complex thereof, preparation method and use for the same |
12/15/2010 | CN1919222B Process for preparing notoginsen triterpenes |
12/15/2010 | CN101918546A Use of a chromatography substrate for reducing the amount of ADAMTS13 in a solution derived from plasma |
12/15/2010 | CN101918366A Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
12/15/2010 | CN101917990A Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
12/15/2010 | CN101917970A Resuscitation fluid |
12/15/2010 | CN101914210A Preparation process of succinylated gelatin |
12/15/2010 | CN101914168A Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof |
12/15/2010 | CN101914088A Piperidine compounds and pharmaceutical compositions containing them |
12/15/2010 | CN101912601A Stabilised solid compositions of factor VII polypeptides |
12/15/2010 | CN101912589A Chinese herbal medicament for treating gestational edema |
12/15/2010 | CN101912523A Traditional Chinese medicine preparation for treating iron-deficiency anemia of children |
12/15/2010 | CN101912500A Chinese medicinal herbs for treating menses relapse of old women |
12/15/2010 | CN101912466A Chinese patent medicament for treating eczema and dermatitis, relieving itching and stopping bleeding |
12/15/2010 | CN101912455A Traditional Chinese medicinal composition for treating blood and vital energy deficiency diseases |
12/15/2010 | CN101912437A Chinese medicinal composition for improving bone marrow depression caused by radiotherapy and chemotherapy and preparation method thereof |
12/15/2010 | CN101912419A Instant donkey-hide glue powder and preparation method thereof |
12/15/2010 | CN101912418A Instant donkey-hide gelatin powder and preparation method thereof |
12/15/2010 | CN101912417A Instant donkey-hide gelatin granules and preparation method thereof |
12/15/2010 | CN101912414A Blood purification base displacing liquid |
12/15/2010 | CN101912402A Composition of cefazedone sodium sterile and clavulanate potassium and proportion thereof |
12/15/2010 | CN101912396A Use of hif alpha stabilizers for enhancing erythropoiesis |
12/15/2010 | CN101912394A Medicinal composition for treating coagulopathy haemorrhage and application and therapeutic method thereof |
12/15/2010 | CN101912393A Solid preparation of clopidogrel or medicinal salts of clopidogrel and preparation method thereof |
12/15/2010 | CN101912391A Deferacirox dispersible tablets |
12/15/2010 | CN101352436B Novel medicament composition for resisting thrombosis |
12/15/2010 | CN101313978B Bacillus coli vaccine oral liquid synergistic agent for livestock, poultry and aquatic product, and preparation method thereof |
12/15/2010 | CN101264077B Lignans and its use for preparing antiphlogistic antiendotoxin medicaments |
12/15/2010 | CN101249170B Preparation of houttuynia cordata freeze-dried powder needle for injections |
12/15/2010 | CN101204572B Preoral Chinese traditional medicine for spleen-stomach deficiency-cold hematemesis |
12/15/2010 | CN101204547B Peroral Chinese traditional medicine for yangcollaterals injury inducing emptysis |
12/15/2010 | CN101199724B Oral administration Chinese medicine for treating liver stomach discord type hematemesis |
12/15/2010 | CN101172959B N,N*-2[fluoroform (oxygen) group] substituted phenyl derivant of 4-methoxy-1,3-benzene diamide and uses of the same |
12/14/2010 | US7851503 xanthocillin analogues such as 3,3'-Dimethoxyxanthocillin X dimethyl ether, used for increasing platelets in a human having a disease selected from thrombocytopenia caused by bone marrow grafting, surgery, infection, intestinal bleeding, anemia, myelodysplastic syndrome, and thrombopoietin deficiency |
12/14/2010 | US7851494 administering 5-[(4-(2,6-difluorobenzyloxy)phenyl)-methyl]-1H-tetrazole for the treatment of insulin resistance, diabetes, hyperlipemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
12/14/2010 | US7851442 and cerebral ischemia and or the onset of systemic inflammatory response particularly when associated with a surgical procedure(especially cardiothoracic surgery; kit comprising a dry lyophilized kallikrein inhibitor DX88 in a hermetically sealed container (rather than aprotinin) |
12/14/2010 | US7851440 Peptides with affinity for a phospholipid and uses |
12/14/2010 | US7850968 Cluster of differentiation 83 specific immunoglobulin for use in treatment of autoimmune and neoplastic disorders |
12/14/2010 | CA2437944C Acylated indanyl amines and their use as pharmaceuticals |
12/14/2010 | CA2336781C Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
12/14/2010 | CA2233316C Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
12/09/2010 | WO2010141949A2 Urea sorbent |
12/09/2010 | WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier |
12/09/2010 | WO2010140401A1 Microneedle array using porous substrate and process for producing same |
12/09/2010 | WO2010139838A1 Genetically modified non-human mammal, cells and methods for producing same |
12/09/2010 | US20100311820 Nucleic acid modulators of glycoprotein vi |
12/09/2010 | US20100311788 Salts of Clopidogrel With Polyanions and Their Use for Manufacturing Pharmaceutical Formulations |
12/09/2010 | US20100311774 Combination Comprising Paclitaxel for Treating Ovarian Cancer |
12/09/2010 | US20100311753 C5aR ANTAGONISTS |
12/09/2010 | US20100311750 Organic compounds |
12/09/2010 | US20100311683 Cytidine analogs for treatment of myelodysplastic syndromes |
12/09/2010 | US20100311659 Novel VIII Factors for the Treatment of Type A Hemophilia |
12/09/2010 | US20100311658 Modified vitamin k-dependent polypeptides |
12/09/2010 | US20100311657 Hemoglobin compositions |
12/09/2010 | US20100311642 Use of v2 receptor antagonists in combination with vaso pressinergic agnosts |
12/09/2010 | US20100311639 Inhibitors of ncca-atp channels for therapy |
12/09/2010 | US20100311189 Novel Receptor Nucleic Acids and Polypeptides |
12/09/2010 | US20100310658 Electroprocessed Fibrin-Based Matrices and Tissues |
12/09/2010 | US20100310650 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation |
12/09/2010 | US20100310646 Selective exosite inhibition of papp-a activity against igfbp-4 |
12/09/2010 | US20100310636 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof |
12/09/2010 | US20100310540 Methods of screening for compounds that modulate tafia activity, compounds, and methods of using the compounds |
12/09/2010 | US20100310537 Method for expanding hematopoietic stem cells using heterocyclic compound |
12/09/2010 | US20100310536 Method for expanding hematopoietic stem cells using heterocyclic compound |
12/09/2010 | US20100310535 Method for expanding hematopoietic stem cells using heterocyclic compound |
12/09/2010 | US20100310525 Wnt pathway stimulation in reprogramming somatic cells |
12/09/2010 | US20100310513 Bifidobacterial species |
12/09/2010 | US20100310510 N-terminally chemically modified protein compositions and methods |
12/09/2010 | US20100310465 Nano-devices having releasable seals for controlled release of molecules |
12/09/2010 | CA2760655A1 Heterocyclic compounds and expansion agents for hematopoietic stem cells |
12/08/2010 | EP2258849A1 Mammalian receptor proteins; related reagents and methods |
12/08/2010 | EP2258722A2 Antibodies to fibroblast growth factor-like (FGF-like) polypeptides |